Security key
09075P105
BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 (BTAI)
CUSIP: 09075P105
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / Common Stock, par value $0.001
- Total 13F shares
- 88
- Total 13F value
- $54
- Share change
- +88
- SEC-reported price per share
- $0.61
- Number of holders
- 1
- Value change
- +$54
- Number of buys
- 1
- Shares outstanding
- 27,093,277
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2025
Institutions
1
Top holders
0
BTAI full security history
Ownership snapshot
Newer quarter: Q4 2025
Previous quarter: Q2 2025
BioXcel Therapeutics, Inc. SEC filings
BioXcel Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 09075P105
Recent filing periods:
Ownership snapshot
Top reported holders of BTAI - BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
15/15
Latest evidence
30 Jun 2025
13D/G
13F
Lead comparable stake: 5%
13D/G row: ARMISTICE CAPITAL, LLC
Showing 1-6 of 15 holder rows.
Quick read
ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Comparable ownership
Top 5
ARMISTICE CAPITAL, LLC
5%
Oaktree Capital Group Holdings GP...
2.7%
OAKTREE CAPITAL MANAGEMENT LP
1.1%
Murchinson Ltd.
0.37%
Oaktree Fund Advisors, LLC
0.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13D/G
|
5%
|
$564,737
288,131 shares
|
-$9,229,922 | 31 Mar 2025 |
| Oaktree Capital Group Holdings GP, LLC |
13D/G
Oaktree Capital Holdings, LLC
|
2.7%
|
$28,939
170,230 shares
|
-$434,154 | 31 Mar 2025 |
| OAKTREE CAPITAL MANAGEMENT LP |
13F
Company
|
1.1%
|
$436,551
241,188 shares
|
— | 30 Jun 2025 |
| Murchinson Ltd. |
13F
Company
|
0.37%
|
$145,919
80,618 shares
|
— | 30 Jun 2025 |
| Oaktree Fund Advisors, LLC |
13F
Company
|
0.2%
|
$77,672
42,913 shares
|
— | 30 Jun 2025 |
| UBS Group AG |
13F
Company
|
0.18%
|
$72,187
39,882 shares
|
— | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Archived quarter
Historical 13F summary for Q3 2025
This older quarter remains available as an indexed ownership summary. Detailed holder rows are no longer kept in the hot table for this period.